ACRS vs CINF · rev $3.6M vs P/E 16, rev $7.14B
Aclaris Therapeutics Inc (ACRS) versus Cincinnati Financial Corporation (CINF) — a side-by-side from cached financials, not a winner call.
Aclaris Therapeutics Inc (ACRS) is a biotechnology company listed on NASDAQ.
Cincinnati Financial Corporation (CINF) is a insurance - property & casualty company listed on US.
Latest reported ACRS revenue for 2026-06-30 was $3.6M. Net income was -$41.3M. Revenue was up 81.6% from 2026-03-31 to 2026-06-30. ACRS currently screens at market cap $615.9M.
Latest reported CINF revenue for 2026-06-30 was $7.14B. Net income was $1.53B. CINF currently screens at market cap $22.83B and trailing P/E 15.9.
ACRS currently screens at market cap $615.9M. CINF currently screens at market cap $22.83B and trailing P/E 15.9.
Not investment advice. Open the ACRS and CINF stock pages for the full models.
Not investment advice.